nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2C9—brain cancer	0.545	1	CbGaD
Isoniazid—CYP2D6—Lomustine—brain cancer	0.062	0.183	CbGbCtD
Isoniazid—CYP1A2—Carmustine—brain cancer	0.0614	0.181	CbGbCtD
Isoniazid—CYP2D6—Hydroxyurea—brain cancer	0.047	0.139	CbGbCtD
Isoniazid—CYP3A4—Temozolomide—brain cancer	0.0464	0.137	CbGbCtD
Isoniazid—CYP3A4—Lomustine—brain cancer	0.0394	0.116	CbGbCtD
Isoniazid—CYP2E1—Etoposide—brain cancer	0.0315	0.0928	CbGbCtD
Isoniazid—CYP2C8—Etoposide—brain cancer	0.0235	0.0693	CbGbCtD
Isoniazid—CYP1A2—Etoposide—brain cancer	0.0182	0.0537	CbGbCtD
Isoniazid—CYP3A4—Etoposide—brain cancer	0.00953	0.0281	CbGbCtD
Isoniazid—Distress—Hydroxyurea—brain cancer	0.00443	0.0635	CcSEcCtD
Isoniazid—Atrophy—Hydroxyurea—brain cancer	0.00378	0.0541	CcSEcCtD
Isoniazid—NAT2—pineal body—brain cancer	0.00311	0.52	CbGeAlD
Isoniazid—Emotional distress—Hydroxyurea—brain cancer	0.00289	0.0414	CcSEcCtD
Isoniazid—Optic neuritis—Procarbazine—brain cancer	0.00258	0.037	CcSEcCtD
Isoniazid—Systemic lupus erythematosus—Hydroxyurea—brain cancer	0.00222	0.0318	CcSEcCtD
Isoniazid—Eruption—Hydroxyurea—brain cancer	0.002	0.0286	CcSEcCtD
Isoniazid—Neurotoxicity—Etoposide—brain cancer	0.00198	0.0284	CcSEcCtD
Isoniazid—Metabolic acidosis—Etoposide—brain cancer	0.00195	0.0279	CcSEcCtD
Isoniazid—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.00178	0.044	CbGpPWpGaD
Isoniazid—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00174	0.0432	CbGpPWpGaD
Isoniazid—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00157	0.0388	CbGpPWpGaD
Isoniazid—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00142	0.0353	CbGpPWpGaD
Isoniazid—Gynaecomastia—Procarbazine—brain cancer	0.00142	0.0204	CcSEcCtD
Isoniazid—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.0014	0.0348	CbGpPWpGaD
Isoniazid—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.0014	0.0346	CbGpPWpGaD
Isoniazid—Hepatic function abnormal—Procarbazine—brain cancer	0.00132	0.0189	CcSEcCtD
Isoniazid—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00127	0.0315	CbGpPWpGaD
Isoniazid—Optic neuritis—Etoposide—brain cancer	0.00125	0.0179	CcSEcCtD
Isoniazid—Memory impairment—Temozolomide—brain cancer	0.00122	0.0175	CcSEcCtD
Isoniazid—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00121	0.0301	CbGpPWpGaD
Isoniazid—Liver injury—Temozolomide—brain cancer	0.00114	0.0164	CcSEcCtD
Isoniazid—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.0011	0.0273	CbGpPWpGaD
Isoniazid—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00109	0.027	CbGpPWpGaD
Isoniazid—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00108	0.0268	CbGpPWpGaD
Isoniazid—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00106	0.0262	CbGpPWpGaD
Isoniazid—Hyperbilirubinaemia—Temozolomide—brain cancer	0.00106	0.0151	CcSEcCtD
Isoniazid—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000996	0.0247	CbGpPWpGaD
Isoniazid—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000991	0.0246	CbGpPWpGaD
Isoniazid—Eosinophilia—Procarbazine—brain cancer	0.000988	0.0141	CcSEcCtD
Isoniazid—Aplastic anaemia—Temozolomide—brain cancer	0.000902	0.0129	CcSEcCtD
Isoniazid—Gynaecomastia—Carmustine—brain cancer	0.00089	0.0127	CcSEcCtD
Isoniazid—Thrombocytopenia—Lomustine—brain cancer	0.000875	0.0125	CcSEcCtD
Isoniazid—Neuropathy peripheral—Procarbazine—brain cancer	0.000872	0.0125	CcSEcCtD
Isoniazid—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.00087	0.0216	CbGpPWpGaD
Isoniazid—Jaundice—Procarbazine—brain cancer	0.000867	0.0124	CcSEcCtD
Isoniazid—Anorexia—Lomustine—brain cancer	0.000852	0.0122	CcSEcCtD
Isoniazid—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000837	0.0207	CbGpPWpGaD
Isoniazid—Diabetes mellitus—Carmustine—brain cancer	0.00083	0.0119	CcSEcCtD
Isoniazid—Body temperature increased—Carboplatin—brain cancer	0.000807	0.0116	CcSEcCtD
Isoniazid—Decreased appetite—Lomustine—brain cancer	0.000777	0.0111	CcSEcCtD
Isoniazid—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000756	0.0187	CbGpPWpGaD
Isoniazid—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000752	0.0186	CbGpPWpGaD
Isoniazid—NAT2—Biological oxidations—CYP2C9—brain cancer	0.000734	0.0182	CbGpPWpGaD
Isoniazid—NAT2—Metapathway biotransformation—CYP2C9—brain cancer	0.000724	0.0179	CbGpPWpGaD
Isoniazid—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000723	0.0179	CbGpPWpGaD
Isoniazid—Body temperature increased—Lomustine—brain cancer	0.000706	0.0101	CcSEcCtD
Isoniazid—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000675	0.00966	CcSEcCtD
Isoniazid—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000671	0.0166	CbGpPWpGaD
Isoniazid—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000646	0.016	CbGpPWpGaD
Isoniazid—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000617	0.0153	CbGpPWpGaD
Isoniazid—Convulsion—Procarbazine—brain cancer	0.000602	0.00862	CcSEcCtD
Isoniazid—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000594	0.0147	CbGpPWpGaD
Isoniazid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000569	0.0141	CbGpPWpGaD
Isoniazid—Vomiting—Lomustine—brain cancer	0.000568	0.00813	CcSEcCtD
Isoniazid—Hyperglycaemia—Carmustine—brain cancer	0.000563	0.00806	CcSEcCtD
Isoniazid—Thrombocytopenia—Procarbazine—brain cancer	0.000555	0.00795	CcSEcCtD
Isoniazid—Neuropathy peripheral—Carmustine—brain cancer	0.000545	0.00781	CcSEcCtD
Isoniazid—Hyperglycaemia—Temozolomide—brain cancer	0.000544	0.00779	CcSEcCtD
Isoniazid—NAT2—endocrine gland—brain cancer	0.000543	0.0907	CbGeAlD
Isoniazid—Anorexia—Procarbazine—brain cancer	0.000541	0.00774	CcSEcCtD
Isoniazid—Nausea—Lomustine—brain cancer	0.000531	0.0076	CcSEcCtD
Isoniazid—Neuropathy peripheral—Temozolomide—brain cancer	0.000527	0.00755	CcSEcCtD
Isoniazid—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000523	0.013	CbGpPWpGaD
Isoniazid—Paraesthesia—Procarbazine—brain cancer	0.000509	0.00729	CcSEcCtD
Isoniazid—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000503	0.0125	CbGpPWpGaD
Isoniazid—Ill-defined disorder—Hydroxyurea—brain cancer	0.000499	0.00715	CcSEcCtD
Isoniazid—Decreased appetite—Procarbazine—brain cancer	0.000493	0.00706	CcSEcCtD
Isoniazid—Fatigue—Procarbazine—brain cancer	0.000489	0.007	CcSEcCtD
Isoniazid—Malaise—Hydroxyurea—brain cancer	0.000485	0.00695	CcSEcCtD
Isoniazid—Hepatitis—Temozolomide—brain cancer	0.000483	0.00691	CcSEcCtD
Isoniazid—Feeling abnormal—Procarbazine—brain cancer	0.000467	0.00669	CcSEcCtD
Isoniazid—Convulsion—Hydroxyurea—brain cancer	0.000466	0.00667	CcSEcCtD
Isoniazid—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000461	0.0114	CbGpPWpGaD
Isoniazid—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000457	0.0113	CbGpPWpGaD
Isoniazid—Discomfort—Hydroxyurea—brain cancer	0.000452	0.00648	CcSEcCtD
Isoniazid—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000451	0.0112	CbGpPWpGaD
Isoniazid—Body temperature increased—Procarbazine—brain cancer	0.000448	0.00642	CcSEcCtD
Isoniazid—Thrombocytopenia—Hydroxyurea—brain cancer	0.00043	0.00615	CcSEcCtD
Isoniazid—Neuropathy peripheral—Etoposide—brain cancer	0.000422	0.00604	CcSEcCtD
Isoniazid—Jaundice—Etoposide—brain cancer	0.000419	0.00601	CcSEcCtD
Isoniazid—Anorexia—Hydroxyurea—brain cancer	0.000418	0.00599	CcSEcCtD
Isoniazid—Hypersensitivity—Procarbazine—brain cancer	0.000418	0.00598	CcSEcCtD
Isoniazid—Asthenia—Procarbazine—brain cancer	0.000407	0.00583	CcSEcCtD
Isoniazid—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000404	0.01	CbGpPWpGaD
Isoniazid—Agranulocytosis—Etoposide—brain cancer	0.000402	0.00575	CcSEcCtD
Isoniazid—Ill-defined disorder—Temozolomide—brain cancer	0.00039	0.00558	CcSEcCtD
Isoniazid—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000388	0.00962	CbGpPWpGaD
Isoniazid—Dyspepsia—Hydroxyurea—brain cancer	0.000386	0.00553	CcSEcCtD
Isoniazid—Decreased appetite—Hydroxyurea—brain cancer	0.000382	0.00546	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000379	0.00543	CcSEcCtD
Isoniazid—Malaise—Temozolomide—brain cancer	0.000379	0.00543	CcSEcCtD
Isoniazid—Fatigue—Hydroxyurea—brain cancer	0.000378	0.00542	CcSEcCtD
Isoniazid—Convulsion—Carmustine—brain cancer	0.000377	0.00539	CcSEcCtD
Isoniazid—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000371	0.00919	CbGpPWpGaD
Isoniazid—Convulsion—Temozolomide—brain cancer	0.000364	0.00521	CcSEcCtD
Isoniazid—Feeling abnormal—Hydroxyurea—brain cancer	0.000362	0.00518	CcSEcCtD
Isoniazid—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000361	0.00896	CbGpPWpGaD
Isoniazid—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000361	0.00896	CbGpPWpGaD
Isoniazid—Vomiting—Procarbazine—brain cancer	0.000361	0.00516	CcSEcCtD
Isoniazid—Rash—Procarbazine—brain cancer	0.000358	0.00512	CcSEcCtD
Isoniazid—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000357	0.00884	CbGpPWpGaD
Isoniazid—Discomfort—Temozolomide—brain cancer	0.000353	0.00506	CcSEcCtD
Isoniazid—Thrombocytopenia—Carmustine—brain cancer	0.000347	0.00497	CcSEcCtD
Isoniazid—Body temperature increased—Hydroxyurea—brain cancer	0.000347	0.00497	CcSEcCtD
Isoniazid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000342	0.00848	CbGpPWpGaD
Isoniazid—Anorexia—Carmustine—brain cancer	0.000338	0.00484	CcSEcCtD
Isoniazid—Nausea—Procarbazine—brain cancer	0.000337	0.00482	CcSEcCtD
Isoniazid—Thrombocytopenia—Temozolomide—brain cancer	0.000336	0.00481	CcSEcCtD
Isoniazid—Anorexia—Temozolomide—brain cancer	0.000327	0.00468	CcSEcCtD
Isoniazid—Hypersensitivity—Hydroxyurea—brain cancer	0.000323	0.00463	CcSEcCtD
Isoniazid—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000322	0.00799	CbGpPWpGaD
Isoniazid—Paraesthesia—Carmustine—brain cancer	0.000319	0.00456	CcSEcCtD
Isoniazid—Asthenia—Hydroxyurea—brain cancer	0.000315	0.00451	CcSEcCtD
Isoniazid—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000312	0.00774	CbGpPWpGaD
Isoniazid—Ill-defined disorder—Etoposide—brain cancer	0.000312	0.00447	CcSEcCtD
Isoniazid—Decreased appetite—Carmustine—brain cancer	0.000308	0.00442	CcSEcCtD
Isoniazid—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000308	0.00764	CbGpPWpGaD
Isoniazid—Paraesthesia—Temozolomide—brain cancer	0.000308	0.00441	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Carmustine—brain cancer	0.000306	0.00439	CcSEcCtD
Isoniazid—Malaise—Etoposide—brain cancer	0.000303	0.00434	CcSEcCtD
Isoniazid—Dyspepsia—Temozolomide—brain cancer	0.000302	0.00432	CcSEcCtD
Isoniazid—Decreased appetite—Temozolomide—brain cancer	0.000298	0.00427	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Temozolomide—brain cancer	0.000296	0.00424	CcSEcCtD
Isoniazid—Fatigue—Temozolomide—brain cancer	0.000296	0.00423	CcSEcCtD
Isoniazid—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000293	0.00726	CbGpPWpGaD
Isoniazid—Feeling abnormal—Carmustine—brain cancer	0.000292	0.00419	CcSEcCtD
Isoniazid—Convulsion—Etoposide—brain cancer	0.000291	0.00417	CcSEcCtD
Isoniazid—Discomfort—Etoposide—brain cancer	0.000283	0.00405	CcSEcCtD
Isoniazid—Feeling abnormal—Temozolomide—brain cancer	0.000283	0.00405	CcSEcCtD
Isoniazid—Body temperature increased—Carmustine—brain cancer	0.000281	0.00402	CcSEcCtD
Isoniazid—Vomiting—Hydroxyurea—brain cancer	0.000279	0.004	CcSEcCtD
Isoniazid—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000279	0.00691	CbGpPWpGaD
Isoniazid—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000277	0.00687	CbGpPWpGaD
Isoniazid—Rash—Hydroxyurea—brain cancer	0.000277	0.00396	CcSEcCtD
Isoniazid—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000275	0.00682	CbGpPWpGaD
Isoniazid—Body temperature increased—Temozolomide—brain cancer	0.000271	0.00388	CcSEcCtD
Isoniazid—Thrombocytopenia—Etoposide—brain cancer	0.000269	0.00385	CcSEcCtD
Isoniazid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000264	0.00655	CbGpPWpGaD
Isoniazid—Anorexia—Etoposide—brain cancer	0.000262	0.00375	CcSEcCtD
Isoniazid—Hypersensitivity—Carmustine—brain cancer	0.000261	0.00374	CcSEcCtD
Isoniazid—Nausea—Hydroxyurea—brain cancer	0.000261	0.00373	CcSEcCtD
Isoniazid—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000256	0.00636	CbGpPWpGaD
Isoniazid—Asthenia—Carmustine—brain cancer	0.000255	0.00365	CcSEcCtD
Isoniazid—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000253	0.00628	CbGpPWpGaD
Isoniazid—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000253	0.00627	CbGpPWpGaD
Isoniazid—Hypersensitivity—Temozolomide—brain cancer	0.000253	0.00362	CcSEcCtD
Isoniazid—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000251	0.00623	CbGpPWpGaD
Isoniazid—Paraesthesia—Etoposide—brain cancer	0.000246	0.00353	CcSEcCtD
Isoniazid—Asthenia—Temozolomide—brain cancer	0.000246	0.00352	CcSEcCtD
Isoniazid—Decreased appetite—Etoposide—brain cancer	0.000239	0.00342	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Etoposide—brain cancer	0.000237	0.00339	CcSEcCtD
Isoniazid—Fatigue—Etoposide—brain cancer	0.000237	0.00339	CcSEcCtD
Isoniazid—Feeling abnormal—Etoposide—brain cancer	0.000226	0.00324	CcSEcCtD
Isoniazid—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000226	0.0056	CbGpPWpGaD
Isoniazid—Vomiting—Carmustine—brain cancer	0.000226	0.00323	CcSEcCtD
Isoniazid—Rash—Carmustine—brain cancer	0.000224	0.0032	CcSEcCtD
Isoniazid—Vomiting—Temozolomide—brain cancer	0.000218	0.00312	CcSEcCtD
Isoniazid—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000217	0.00538	CbGpPWpGaD
Isoniazid—Body temperature increased—Etoposide—brain cancer	0.000217	0.00311	CcSEcCtD
Isoniazid—Rash—Temozolomide—brain cancer	0.000216	0.0031	CcSEcCtD
Isoniazid—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000214	0.00531	CbGpPWpGaD
Isoniazid—Nausea—Carmustine—brain cancer	0.000211	0.00302	CcSEcCtD
Isoniazid—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000209	0.00517	CbGpPWpGaD
Isoniazid—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000208	0.00515	CbGpPWpGaD
Isoniazid—Nausea—Temozolomide—brain cancer	0.000204	0.00292	CcSEcCtD
Isoniazid—Hypersensitivity—Etoposide—brain cancer	0.000202	0.00289	CcSEcCtD
Isoniazid—CYP2D6—hindbrain—brain cancer	0.000198	0.033	CbGeAlD
Isoniazid—Asthenia—Etoposide—brain cancer	0.000197	0.00282	CcSEcCtD
Isoniazid—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000197	0.00488	CbGpPWpGaD
Isoniazid—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000176	0.00436	CbGpPWpGaD
Isoniazid—Vomiting—Etoposide—brain cancer	0.000174	0.0025	CcSEcCtD
Isoniazid—Rash—Etoposide—brain cancer	0.000173	0.00248	CcSEcCtD
Isoniazid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000168	0.00416	CbGpPWpGaD
Isoniazid—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000165	0.0041	CbGpPWpGaD
Isoniazid—Nausea—Etoposide—brain cancer	0.000163	0.00233	CcSEcCtD
Isoniazid—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000156	0.00386	CbGpPWpGaD
Isoniazid—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000153	0.0038	CbGpPWpGaD
Isoniazid—CYP2A6—cerebellum—brain cancer	0.000149	0.0249	CbGeAlD
Isoniazid—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000142	0.00353	CbGpPWpGaD
Isoniazid—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000136	0.00337	CbGpPWpGaD
Isoniazid—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000134	0.00333	CbGpPWpGaD
Isoniazid—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000133	0.00329	CbGpPWpGaD
Isoniazid—CYP2E1—telencephalon—brain cancer	0.000127	0.0212	CbGeAlD
Isoniazid—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000126	0.00313	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—CYP2C9—brain cancer	0.000126	0.00311	CbGpPWpGaD
Isoniazid—CYP2C8—pituitary gland—brain cancer	0.000123	0.0205	CbGeAlD
Isoniazid—CYP2A6—brain—brain cancer	0.000121	0.0203	CbGeAlD
Isoniazid—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.00012	0.00298	CbGpPWpGaD
Isoniazid—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000118	0.00293	CbGpPWpGaD
Isoniazid—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000116	0.00287	CbGpPWpGaD
Isoniazid—CYP2D6—brainstem—brain cancer	0.000113	0.0189	CbGeAlD
Isoniazid—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.00011	0.00274	CbGpPWpGaD
Isoniazid—CYP2C19—endocrine gland—brain cancer	0.000109	0.0182	CbGeAlD
Isoniazid—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000109	0.0027	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—BSG—brain cancer	0.000107	0.00265	CbGpPWpGaD
Isoniazid—CYP2D6—telencephalon—brain cancer	0.0001	0.0168	CbGeAlD
Isoniazid—CYP2E1—medulla oblongata—brain cancer	9.97e-05	0.0167	CbGeAlD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	9.65e-05	0.00239	CbGpPWpGaD
Isoniazid—CYP2C8—endocrine gland—brain cancer	9.51e-05	0.0159	CbGeAlD
Isoniazid—CYP1A2—Biological oxidations—CYP2C9—brain cancer	9.35e-05	0.00232	CbGpPWpGaD
Isoniazid—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	9.22e-05	0.00229	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—IDH1—brain cancer	9.18e-05	0.00227	CbGpPWpGaD
Isoniazid—CYP1A2—endocrine gland—brain cancer	8.9e-05	0.0149	CbGeAlD
Isoniazid—CYP2E1—spinal cord—brain cancer	8.89e-05	0.0149	CbGeAlD
Isoniazid—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	8.84e-05	0.00219	CbGpPWpGaD
Isoniazid—CYP2C9—endocrine gland—brain cancer	8.45e-05	0.0141	CbGeAlD
Isoniazid—CYP2E1—endocrine gland—brain cancer	8e-05	0.0134	CbGeAlD
Isoniazid—CYP2E1—head—brain cancer	7.9e-05	0.0132	CbGeAlD
Isoniazid—NAT2—Metabolism—ENO2—brain cancer	7.25e-05	0.0018	CbGpPWpGaD
Isoniazid—CYP3A4—Biological oxidations—CYP2C9—brain cancer	7.22e-05	0.00179	CbGpPWpGaD
Isoniazid—CYP2E1—central nervous system—brain cancer	7.21e-05	0.0121	CbGeAlD
Isoniazid—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	7.12e-05	0.00176	CbGpPWpGaD
Isoniazid—CYP2E1—cerebellum—brain cancer	7.05e-05	0.0118	CbGeAlD
Isoniazid—CYP2C8—brain—brain cancer	6.8e-05	0.0114	CbGeAlD
Isoniazid—CYP3A4—endocrine gland—brain cancer	6.44e-05	0.0108	CbGeAlD
Isoniazid—CYP2D6—endocrine gland—brain cancer	6.34e-05	0.0106	CbGeAlD
Isoniazid—CYP2D6—head—brain cancer	6.26e-05	0.0105	CbGeAlD
Isoniazid—CYP3A4—central nervous system—brain cancer	5.8e-05	0.0097	CbGeAlD
Isoniazid—CYP2E1—brain—brain cancer	5.73e-05	0.00957	CbGeAlD
Isoniazid—CYP2D6—central nervous system—brain cancer	5.71e-05	0.00954	CbGeAlD
Isoniazid—CYP2D6—cerebellum—brain cancer	5.58e-05	0.00933	CbGeAlD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.56e-05	0.00138	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.16e-05	0.00128	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.01e-05	0.00124	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.61e-05	0.00114	CbGpPWpGaD
Isoniazid—CYP2D6—brain—brain cancer	4.53e-05	0.00758	CbGeAlD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.26e-05	0.00106	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.92e-05	0.000972	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.83e-05	0.00095	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.83e-05	0.00095	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.78e-05	0.000936	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.59e-05	0.00089	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.37e-05	0.000835	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CYP2C9—brain cancer	3.37e-05	0.000835	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—PIK3CG—brain cancer	3.33e-05	0.000825	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.07e-05	0.000762	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—BSG—brain cancer	2.86e-05	0.00071	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYP2C9—brain cancer	2.66e-05	0.00066	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.63e-05	0.000651	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—IDH1—brain cancer	2.46e-05	0.00061	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP2C9—brain cancer	2.3e-05	0.00057	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—BSG—brain cancer	2.26e-05	0.000561	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP2C9—brain cancer	2.05e-05	0.000509	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—BSG—brain cancer	1.96e-05	0.000485	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—ENO2—brain cancer	1.95e-05	0.000482	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—IDH1—brain cancer	1.95e-05	0.000482	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP2C9—brain cancer	1.89e-05	0.000468	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—BSG—brain cancer	1.75e-05	0.000433	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—IDH1—brain cancer	1.68e-05	0.000417	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—BSG—brain cancer	1.61e-05	0.000398	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP2C9—brain cancer	1.6e-05	0.000396	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—BSG—brain cancer	1.59e-05	0.000395	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ENO2—brain cancer	1.54e-05	0.000381	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—IDH1—brain cancer	1.5e-05	0.000372	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—IDH1—brain cancer	1.38e-05	0.000342	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.37e-05	0.000339	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—IDH1—brain cancer	1.37e-05	0.000339	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—BSG—brain cancer	1.36e-05	0.000337	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ENO2—brain cancer	1.33e-05	0.000329	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP2C9—brain cancer	1.23e-05	0.000306	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.22e-05	0.000303	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ENO2—brain cancer	1.19e-05	0.000294	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—IDH1—brain cancer	1.17e-05	0.00029	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.11e-05	0.000276	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ENO2—brain cancer	1.09e-05	0.000271	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ENO2—brain cancer	1.08e-05	0.000268	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—BSG—brain cancer	1.05e-05	0.00026	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.52e-06	0.000236	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ENO2—brain cancer	9.24e-06	0.000229	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—IDH1—brain cancer	9.02e-06	0.000224	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CG—brain cancer	8.93e-06	0.000221	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ENO2—brain cancer	7.13e-06	0.000177	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CG—brain cancer	7.05e-06	0.000175	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CG—brain cancer	6.1e-06	0.000151	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CG—brain cancer	5.44e-06	0.000135	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CG—brain cancer	5.01e-06	0.000124	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CG—brain cancer	4.96e-06	0.000123	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CG—brain cancer	4.24e-06	0.000105	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CG—brain cancer	3.27e-06	8.11e-05	CbGpPWpGaD
